Loading organizations...
§ Private Profile · Palo Alto, CA, USA
Biotechnology company developing targeted cancer chemo-immunotherapies.
MaveriX Oncology has raised $6.5M across 1 funding round.
MaveriX Oncology has raised $6.5M in total across 1 funding round.
MaveriX Oncology has raised $6.5M across 1 funding round. Most recently, it raised $6.5M Series A in October 2019.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Oct 14, 2019 | $6.5M Series A | PPF Group | — | Announced |
MaveriX Oncology has raised $6.5M in total across 1 funding round.
MaveriX Oncology's investors include PPF Group.